SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001384101-22-000137
Filing Date
2022-11-02
Accepted
2022-11-02 16:11:57
Documents
14
Period of Report
2022-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vcyt-20221102.htm   iXBRL 8-K 37850
2 EX-99.1 vcyt-1102228xkearningsrele.htm EX-99.1 297592
6 GRAPHIC veracytelogoa10.jpg GRAPHIC 10166
  Complete submission text file 0001384101-22-000137.txt   513005

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcyt-20221102.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcyt-20221102_lab.xml EX-101.LAB 25250
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcyt-20221102_pre.xml EX-101.PRE 13154
8 EXTRACTED XBRL INSTANCE DOCUMENT vcyt-20221102_htm.xml XML 11959
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

IRS No.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 221354187
SIC: 8071 Services-Medical Laboratories